Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
250 participants
INTERVENTIONAL
2017-06-15
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
sodium creatine phosphate
5g creatine phosphate was dissolved in 50ml saline solution. After induction of anesthesia, the patients were first given a load dose of 1g, 20min (30ml / h) , And then pumped at a rate of 1 g / h (10 ml / h).
sodium creatine phosphate
sodium creatine phosphate .Loading dose followed by continuous infusion in operation
Control
The control group was treated with saline in the same manner.
saline
.Loading dose followed by continuous infusion in operation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sodium creatine phosphate
sodium creatine phosphate .Loading dose followed by continuous infusion in operation
saline
.Loading dose followed by continuous infusion in operation
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* other organ dysfunction: such as cancer, organ failure, severe anemia, infection
* patients with mental disorders
* coagulopathy, active ulcer, ischemic or hemorrhagic stroke (within 6 months), trauma
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese Academy of Medical Sciences, Fuwai Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Guyan Wang
The Chief of Infection-Control Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guyan WANG, M.D.
Role: STUDY_DIRECTOR
Department of anesthesiology,Fuwai hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Anesthesiology ,Fuwai Hospital, National Center for Cardiovascular Diseases, CAMS and PUMC
Beijing, Beijing Municipality, China
Cardiovascular Institute and Fuwai Hospital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Guyan WANG, M.D.
Role: primary
Guyan Wang, M.D.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FWT2017-ZX004
Identifier Type: -
Identifier Source: org_study_id